Survivorship Bias in Analyses of Immune Checkpoint Inhibitor Trials-In Reply
JAMA Oncol
.
2019 Aug 1;5(8):1226-1227.
doi: 10.1001/jamaoncol.2019.1190.
Authors
Yukihiro Toi
1
,
Shunichi Sugawara
1
Affiliation
1
Department of Pulmonary Medicine, Sendai Kousei Hospital, Miyagi, Japan.
PMID:
31169864
DOI:
10.1001/jamaoncol.2019.1190
No abstract available